BRAHMS Procalcitonin (PCT) Market
BRAHMS Procalcitonin (PCT) Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
BRAHMS Procalcitonin (PCT) Market Size and Growth
The BRAHMS Procalcitonin (PCT) market is experiencing significant growth driven by increasing sepsis awareness and demand for rapid diagnostic solutions. The global market size is projected to reach approximately $500 million by 2025, with a compound annual growth rate (CAGR) of around 7% as healthcare providers prioritize early detection and treatment.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Fujirebio
◍ Siemens
◍ Roche Diagnostics
◍ Thermo Fisher
◍ bioMerieux
◍ Abbott
◍ Samsung
The BRAHMS Procalcitonin (PCT) market features key players like Fujirebio, Siemens, Roche Diagnostics, Thermo Fisher, bioMerieux, Abbott, and Samsung, who leverage PCT for infection diagnostics. Their innovations and product expansions drive market growth through enhanced accuracy and efficiency in sepsis management. Select sales revenues include:
- Roche Diagnostics: $69 billion
- Abbott: $43 billion
- Thermo Fisher: $39 billion.
Request Sample Report
Market Segmentation
By Application
◍ Veterinarian
By Product
◍ Procalcitonin Antigen
◍ Procalcitonin Antibody ◍ Medical Industry
◍ Scientific Research
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
